Substance Use Disorder Treatment for People with Co-Occurring Disorders, Module 2 (Revised 2025) (6 hours)
- Credit Hours: 6 Hours
- Author: John Tinsley
- Price: $78.00
Learning Objectives
Upon completion of this course, participants will be able to:
• Identify the mental disorders that most commonly co-occur with substance use disorders, including mood disorders, anxiety disorders, personality disorders, and psychotic disorders.
• Describe how major depressive disorder, bipolar I disorder, and persistent depressive disorder present in individuals with co-occurring substance use disorders.
• Explain the clinical presentation and treatment considerations for PTSD, generalized anxiety disorder, panic disorder, and social anxiety disorder in SUD treatment settings.
• Analyze the unique challenges of treating borderline and antisocial personality disorders in clients who also have substance use disorders.
• Describe the clinical features and treatment approaches for schizophrenia and other psychotic disorders in individuals with co-occurring SUDs.
• Identify how ADHD and eating disorders intersect with substance use disorders and describe relevant treatment considerations.
• Explain cross-cutting issues of suicide risk and trauma in clients with co-occurring disorders and describe appropriate clinical responses.
• Apply evidence-based competencies and strategies for building successful therapeutic relationships with clients who have CODs.
• Describe how counselors may need to modify SUD treatment approaches when a co-occurring mental disorder is present.
Package Contents
Course Update
About the Instructor
John Tinsley
Dr. John H. Tinsley is a former assistant professor of Medical Physiology at the Texas A&M University System College of Medicine. He received his Ph.D. from Texas A&M University, College Station, Texas; M.S. from the University of North Carolina; and his B.S. from the University of Oklahoma.
He has been teaching, training, consulting and conducting research in the fields of Medical Physiology and Behavioral Biology for over twenty-nine years. Dr. Tinsley has authored over twenty-five professional and refereed articles, including invited reviews. He has been a member of the American Society for Physiology, and work done in 2001 led to an international award from The European Society on Microcirculation. Dr. Tinsley has received research funding from the Veteran’s Administration, American Heart Association, and Scott and White Hospital. In addition, he has served on numerous review committees for national grant-funding agencies and scientific journals.
Approved and Widely Recognized
CEU Matrix is approved by the following national and state accreditation boards:
CEU Matrix is approved with the following state boards:
Arkansas (ASACB), California (CCAPP #OS-07-394-0222), California (CADTP #250), Connecticut (#0115-5202), Delaware (DCB #37), Florida (FCB #5141-A), Georgia (ADACBGA #2026-4-003), Illinois (IAODAPCA #19345), Kentucky, Louisiana (LA ADRA #E026), Michigan (MCBAP), Missouri (Missouri CB #183), New Mexico (NMCBBHP #2046), North Carolina (NCSAPPB), Ohio (OCDP #50-19236), Oklahoma (OBLADS #20260153), Texas (TCB #1758-07)
